中湛股份有限公司 Approved
最後更新時間 2025/06/03 , 03:50 AM
最後更新時間 2025/06/03 , 03:50 AM
負責人
Xu,Zhi-Hong
統一編號
16094290
成立日期
1997/10/02
資本額
NT$1,000,000,000
實收資本額
NT$416,540,390
股票代號
6236
電話
02-77230555
地址
10F, No. 51, Sec. 2, Gongyi Rd., Nantun Dist., Taichung City, 408, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zhou,Jian-Jun Chairman 12.00% FENG LI FU Co., Ltd.
Xu,Zhi-Hong Director 3.84% YUAN LI ASSET MANAGEMENT CO., LTD.
Lin,Bai-Yu Director 13.20% HAN QING INTERNATIONAL CO., LTD.
Zhang,Jun-Jia Director 17.53% ZHONG DA ASSET MANAGEMENT CO., LTD.
Chen,Xuan-Hong Director 12.48% JU HE FA ASSET MANAGEMENT CO., LTD.
Xu,Bo-Jun Director 0.00%
Chen,Jin-Hua Independent Director 0.00%
Luo,Wen-Xin Independent Director 0.00%
Rao,Hong-Peng Independent Director 0.00%
營業項目
  • Other Information Service Activities(639099)
  • Wholesale of Other Food(454999)
  • Wholesale of Cosmetics(457299)
  • Manufacture of Other Electronic Parts and Components Not Elsewhere Classified(269999)
  • 公司歷程
  • Change Company Name to Neith Corporation
    2024/03/20
  • Change Company Name to ZHONGZHAN CO., LTD. (FORMER NAME: KANGCHENG TECHNOLOGY CO., LTD.)
    2023/07/07
  • Change Company Name to KANGCHENG TECHNOLOGY CO., LTD. (FORMER NAME: KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD.)
    2022/07/20
  • Change Company Name to KANGCHENG TECHNOLOGY CO., LTD. (FORMER NAME: KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD.)
    2022/07/07
  • Change Company Name to Neith Corporation
    2022/07/07
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2022/01/06
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2019/12/27
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2019/12/27
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2019/12/27
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2019/11/05
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2019/11/05
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2019/08/26
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2019/08/26
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2019/07/16
  • Change Person in Charge to Zhou,Jian-Jun
    2019/07/16
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2018/07/09
  • Change Person in Charge to Guo,Heng-Cun
    2018/07/09
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2018/07/06
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2018/07/06
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2017/07/14
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2017/07/14
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2017/01/19
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2016/08/17
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2016/08/17
  • Change Company Name to KANGCHENG BIOMEDICAL TECHNOLOGY CO., LTD. (FORMER NAME: LINGYUE TECHNOLOGY CO., LTD.)
    2014/06/24
  • Change Company Name to COME TRUE BIOMEDICAL INC.
    2014/06/24
  • Change Person in Charge to Wu,Jun-Yi
    2013/09/16
  • Change Person in Charge to Tang,Wei-Zhi
    2013/07/02
  • Change Person in Charge to Yang,Wei-Hong
    2011/07/08
  • 員工人數
    財務報表
    項目 2025 2024 2023
    Operating income 12,111 45,571 39,903
    Operating cost 1,956 11,852 21,884
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 10,155 33,719 18,019
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 10,155 33,719 18,019
    Operating expenses 8,768 58,604 66,873
    Other gain (loss), net - - -
    Operating profit (loss) 1,387 -24,885 -48,854
    Non-operating income and expenses 1,395 8,001 8,821
    Net profit (loss) before tax 2,782 -16,884 -40,033
    Income tax expense (benefits) 0 0 0
    Net profit (loss) of ongoing business for the current period 2,782 -16,884 -40,033
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 2,782 -16,884 -40,033
    Other comprehensive profit (loss), net -630 -3,517 6,263
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 2,152 -20,401 -33,770
    Net profit (loss) attributable to owners of parent company 2,782 -16,884 -40,033
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 2,152 -20,401 -33,770
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 0 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 3,171 -27,992 -17,644
    Net cash inflows (outflows) from investing activities 848 10,058 -6,718
    Net cash inflow (outflow) from financing activities -714 -2,827 -3,570
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period 3,305 -20,761 -27,932
    Beginning balance of cash and cash equivalents 133,091 153,852 181,784
    Ending balance of cash and cash equivalents 136,396 133,091 153,852
    項目 2025 2024 2023
    Current asset 147,385 142,924 166,012
    Non-current asset 25,347 27,961 26,141
    Total asset 172,732 170,885 192,153
    Current liability 10,006 9,566 16,431
    Non-current liability 6,255 7,000 1,002
    Total liability 16,261 16,566 17,433
    share capital 416,540 416,540 416,540
    Equity - secruity token - - -
    capital reserve 0 0 0
    retained earning -259,461 -262,243 -245,359
    Other equity -608 22 3,539
    Treasury stock - - -
    Total equity attributable to owners of parent company 156,471 154,319 174,720
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 156,471 154,319 174,720
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 3 3 4
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
    專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。